Median expression level of BCL2 in cohort of 51 AML-NK patients at diagnosis was 1.22 (range 0.13–8.97), which was not significantly different compared to healthy controls (median 1.00, range 0.21–1.59) (P = 0.148). The gene discussed is BCL2; the disease is acute myeloid leukemia.